. 2006 May 11;2006(4):93253. doi: 10.1155/MI/2006/93253

Table 1.

Analysis of serum liver function indexes. Data are presented as mean ± standard error of the mean. N represented the normal control group; M represented the model group; L represented the group treated with low dose of thalidomide; H represented the group treated with high dose of thalidomide.


Groups	n	ALT(U/L)	AST(U/L)	PA(mg/dL)	ALB(g/L)	GLB(g/L)
N	15	48.41 ± 7.06	118.11 ± 10.76	1.03 ± 0.23	42.65 ± 2.34	30.34 ± 1.33
M	10	160.49 ± 8.14^a	485.89 ± 9.36^a	0.44 ± 0.10^a	33.21 ± 2.16^a	31.24 ± 1.02
L	12	136.73 ± 6.39^ab	216.82 ± 7.80^ab	0.53 ± 0.09^a	34.58 ± 0.72^a	30.43 ± 1.20
H	14	62.48 ± 7.08^ab ^c	141.49 ± 9.53^ab ^c	1.31 ± 0.14^ab ^c	40.59 ± 1.39^ab ^c	30.88 ± 1.29

^aP < .01 versus normal control group; ^bP < .01 versus model group;

^cP < .01 group treated with high dose of thalidomide versus group treated with low dose of thalidomide.